Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study.

Mohammadreza BordbarRenée de MutsertMelike CevvalFrits R RosendaalJ Wouter JukemaWillem M Lijfering

Published in: Thrombosis journal (2021)

Current statin use was associated with lower plasma levels of FXI than fibrate/niacin use. The effects on coagulation factors may, in part, explain the benefit of statin therapy rendered in primary and secondary prevention of VTE.

Keyphrases

cardiovascular disease
coronary artery disease
venous thromboembolism
low density lipoprotein
type diabetes
stem cells
smoking cessation